Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Corbion N.V. M&A Activity 2007

Jun 1, 2007

3826_iss_2007-06-01_abe1ddb0-b228-4d5a-96ad-893a7fc0188d.pdf

M&A Activity

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

CSM nv Corporate Communications

P.O. Box 349 1000 AH Amsterdam The Netherlands

Nienoord 13 1112 XE Diemen

T +31 (0)20 590 62 16 F +31 (0)20 590 62 17 E [email protected]

Press Release

CSM SELLS PART OF ITS BAKERY OPERATIONS IN FRANCE

Diemen, the Netherlands, 01 June 2007 – CSM announces that it has reached agreement with Neuhauser on the sale of the frozen bread operations of its subsidiary Délices de la Tour (DLT) in Maubeuge, France.

CSM expects to effectuate the transaction in the short term. The selling price excluding inventories amounts to EUR 7.7 million, more or less equalling bookvalue. Sales amount to approximately EUR 15 million. All dedicated staff (around 93) will be transferred to the new owner. Neuhauser is a leading French producer of, amongst others, frozen bakery products (total sales of around EUR 250 million).

This transaction follows the sale of the viennoiserie operations of DLT in Le Mans earlier this year.

-----------------------------------------------------------------------------------------------------------------------

For more information, please contact:

Press: Corporate Communications: tel. +31 (0)20 5906216 Analysts: Ian Blackford, Investor Relations Manager: tel. +31 (0)20 5906317 / cell phone +44 (0)7767 227506

Background Information

CSM is a global producer and distributor of bakery products and food ingredients. CSM's main product groups are bakery ingredients and products, lactic acid, and lactic acid derivatives. With these activities CSM generates annual sales of EUR 2.4 billion; it has a workforce of around 8,200. CSM operates in Europe, North America, Brazil, and Asia. For more information: www.csm.nl